Spirometer Flow Sensor Market Seen Reaching $1.55 Billion by 2030

The spirometer flow sensor market is projected to grow from $1 billion in 2025 to $1.55 billion by 2030, driven by rising respiratory disease rates, higher healthcare spending and demand for remote monitoring. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Spirometer flow sensors are becoming more important as health systems expand respiratory testing, remote monitoring and home-based care. - The market’s growth reflects rising demand for tools that can detect lung problems earlier and track chronic disease more accurately.

What happened: - The spirometer flow sensor market is projected to rise from $1 billion in 2025 to $1.09 billion in 2026. - The market is forecast to reach $1.55 billion by 2030. - That implies an 8.8% CAGR from 2025 to 2026 and a 9.1% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest during the forecast period.

The details: - Spirometer flow sensors measure the volume and speed of air inhaled and exhaled. - The sensors convert airflow variations into electrical signals used to assess respiratory function. - The market’s recent growth has been supported by rising chronic respiratory illness rates, broader use of hospital pulmonary function tests, greater awareness of early lung disease detection, expansion of diagnostic laboratory infrastructure and the introduction of basic digital spirometry technology. - Forecast growth is tied to demand for remote respiratory monitoring, home healthcare and telemedicine, AI-enhanced diagnostic precision, preventive respiratory screening and connected medical devices. - Leading product trends include AI-powered respiratory diagnostics, IoT-enabled sensors for remote monitoring, cloud-based pulmonary function testing, portable and handheld spirometry devices for home use and higher demand for digital airflow measurement tools in clinical settings. - The increasing prevalence of respiratory diseases is a major demand driver. - Air pollution is contributing to more respiratory illness through exposure to fine particulate matter, vehicle emissions and industrial smoke. - In March 2025, the UK Health Security Agency reported tuberculosis cases in England rose 13% in 2024 to 5,480 from 4,850 in 2023. - Higher healthcare spending is also supporting adoption of respiratory diagnostic devices. - UK total healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms from 2023 to 2024, according to the Office for National Statistics. - UK government-funded healthcare spending reached $328 billion (£258 billion) in 2024, up 2.5% in real terms from the prior year.

Between the lines: - The market outlook points to a shift from basic spirometry toward connected, software-enabled respiratory diagnostics. - Faster growth in Asia-Pacific suggests expanding access to testing and monitoring in markets where respiratory disease burdens and healthcare investment are rising. - The emphasis on remote care and AI indicates buyers are looking for devices that fit both clinical workflows and home-use models.

What's next: - The market is likely to keep moving toward portable, connected and AI-assisted diagnostic tools. - Preventive screening programs and telemedicine adoption are expected to remain central growth drivers. - Regional growth may continue to outpace mature markets where adoption is already more established.

The bottom line: - Spirometer flow sensors are moving from niche diagnostic tools to a broader respiratory monitoring market, with chronic disease, digital health and healthcare spending all pushing demand higher.